154 related articles for article (PubMed ID: 28267544)
21. Magnetic resonance imaging of the breast as a problem-solving method: to be or not to be?
Oztekin PS; Kosar PN
Breast J; 2014; 20(6):622-31. PubMed ID: 25200378
[TBL] [Abstract][Full Text] [Related]
22. Diagnosis and treatment of breast fibroadenomas by ultrasound-guided vacuum-assisted biopsy.
Sperber F; Blank A; Metser U; Flusser G; Klausner JM; Lev-Chelouche D
Arch Surg; 2003 Jul; 138(7):796-800. PubMed ID: 12860764
[TBL] [Abstract][Full Text] [Related]
23. Multicenter study of ultrasound real-time tissue elastography in 779 cases for the assessment of breast lesions: improved diagnostic performance by combining the BI-RADS®-US classification system with sonoelastography.
Wojcinski S; Farrokh A; Weber S; Thomas A; Fischer T; Slowinski T; Schmidt W; Degenhardt F
Ultraschall Med; 2010 Oct; 31(5):484-91. PubMed ID: 20408116
[TBL] [Abstract][Full Text] [Related]
24. Cellular fibroepithelial lesions diagnosed on core needle biopsy: Is there any role of clinical-sonography features helping to differentiate fibroadenomas and phyllodes tumor?
Al-Arnawoot B; Scaranelo A; Fleming R; Kulkarni S; Menezes RJ; McCready D; Done S; Freitas V
J Surg Oncol; 2020 Sep; 122(3):382-387. PubMed ID: 32396665
[TBL] [Abstract][Full Text] [Related]
25. Imaging and Histopathologic Features of BI-RADS 3 Lesions Upgraded during Imaging Surveillance.
Michaels A; Chung CS; Birdwell RL; Frost EP; Giess CS
Breast J; 2017 Jan; 23(1):10-16. PubMed ID: 27612001
[TBL] [Abstract][Full Text] [Related]
26. Characteristics, Malignancy Rate, and Follow-up of BI-RADS Category 3 Lesions Identified at Breast MR Imaging: Implications for MR Image Interpretation and Management.
Chikarmane SA; Birdwell RL; Poole PS; Sippo DA; Giess CS
Radiology; 2016 Sep; 280(3):707-15. PubMed ID: 27089027
[TBL] [Abstract][Full Text] [Related]
27. Revisiting the mammographic follow-up of BI-RADS category 3 lesions.
Varas X; Leborgne JH; Leborgne F; Mezzera J; Jaumandreu S; Leborgne F
AJR Am J Roentgenol; 2002 Sep; 179(3):691-5. PubMed ID: 12185047
[TBL] [Abstract][Full Text] [Related]
28. Comparison of rate of development and rate of change for benign and malignant breast calcifications at the lumpectomy bed.
Giess CS; Keating DM; Osborne MP; Mester J; Rosenblatt R
AJR Am J Roentgenol; 2000 Sep; 175(3):789-93. PubMed ID: 10954468
[TBL] [Abstract][Full Text] [Related]
29. [Second reading of breast imaging at the hospital department of radiology: reasonable or waste of money?].
Teifke A; Vomweg TW; Hlawatsch A; Nasresfahani A; Kern A; Victor A; Schmidt M; Bittinger F; Düber C
Rofo; 2006 Mar; 178(3):330-6. PubMed ID: 16508842
[TBL] [Abstract][Full Text] [Related]
30. BI-RADS category 3, 4, and 5 lesions identified at preoperative breast MRI in patients with breast cancer: implications for management.
Lee SE; Lee JH; Han K; Kim EK; Kim MJ; Moon HJ; Yoon JH; Park VY
Eur Radiol; 2020 May; 30(5):2773-2781. PubMed ID: 32006168
[TBL] [Abstract][Full Text] [Related]
31. Differential diagnosis between fibroadenoma, giant fibroadenoma and phyllodes tumour: sonographic features and core needle biopsy.
Gatta G; Iaselli F; Parlato V; Di Grezia G; Grassi R; Rotondo A
Radiol Med; 2011 Sep; 116(6):905-18. PubMed ID: 21509559
[TBL] [Abstract][Full Text] [Related]
32. Fibroadenoma: can fine needle aspiration biopsy avoid short term follow-up?
Leconte I; Abraham C; Galant C; Sy M; Berlière M; Fellah L
Diagn Interv Imaging; 2012 Oct; 93(10):750-6. PubMed ID: 22999986
[TBL] [Abstract][Full Text] [Related]
33. Sonographic features of histopathologically benign solid breast lesions that have been classified as BI-RADS 4 on sonography.
Taskin F; Koseoglu K; Ozbas S; Erkus M; Karaman C
J Clin Ultrasound; 2012 Jun; 40(5):261-5. PubMed ID: 22508447
[TBL] [Abstract][Full Text] [Related]
34. Computer-aided classification of BI-RADS category 3 breast lesions.
Buchbinder SS; Leichter IS; Lederman RB; Novak B; Bamberger PN; Sklair-Levy M; Yarmish G; Fields SI
Radiology; 2004 Mar; 230(3):820-3. PubMed ID: 14739315
[TBL] [Abstract][Full Text] [Related]
35. Solid breast lesions: diagnosis with US-guided fine-needle aspiration biopsy.
Gordon PB; Goldenberg SL; Chan NH
Radiology; 1993 Nov; 189(2):573-80. PubMed ID: 8210392
[TBL] [Abstract][Full Text] [Related]
36. Management of Pediatric Breast Masses: A Multi-institutional Retrospective Cohort Study.
Lawrence AE; Saito J; Onwuka A; Port E; Bowder A; Courtney C; Deans KJ; Downard CD; Duran YK; Fallat ME; Fraser JD; Gadepalli S; Kabre R; Kalbfell EL; Knaus ME; Kohler J; Lal D; Landman MP; Leys CM; Lu P; Mak GZ; Markel T; Merchant N; Nguyen T; Pilkington M; Rymeski B; Sato TT; St Peter SD; Wright T; Minneci PC; Grabowski JE
J Surg Res; 2021 Aug; 264():309-315. PubMed ID: 33845414
[TBL] [Abstract][Full Text] [Related]
37. Core needle biopsy as a diagnostic tool to differentiate phyllodes tumor from fibroadenoma.
Komenaka IK; El-Tamer M; Pile-Spellman E; Hibshoosh H
Arch Surg; 2003 Sep; 138(9):987-90. PubMed ID: 12963656
[TBL] [Abstract][Full Text] [Related]
38. Clinical and radiologic data and core needle biopsy findings should dictate management of cellular fibroepithelial tumors of the breast.
Resetkova E; Khazai L; Albarracin CT; Arribas E
Breast J; 2010; 16(6):573-80. PubMed ID: 21070433
[TBL] [Abstract][Full Text] [Related]
39. Computer aided classification system for breast ultrasound based on Breast Imaging Reporting and Data System (BI-RADS).
Shen WC; Chang RF; Moon WK
Ultrasound Med Biol; 2007 Nov; 33(11):1688-98. PubMed ID: 17681678
[TBL] [Abstract][Full Text] [Related]
40. US follow-up protocol in concordant benign result after US-guided 14-gauge core needle breast biopsy.
Youk JH; Jung I; Kim EK; Kim MJ; Son EJ; Moon HJ; Kwak JY
Breast Cancer Res Treat; 2012 Apr; 132(3):1089-97. PubMed ID: 22218886
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
